The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
845
May 31, 1991
View Complete Issue         Table of Contents 2019 
Bepridil for Angina Pectoris
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Bepridil for Angina Pectoris
May 31, 1991 (Issue: 845)
Bepridil hydrochloride (Vascor - McNeil Pharmaceutical/Wallace Laboratories), a calcium-channel blocking agent chemically unrelated to verapamil (Calan, and others), nifedipine (Procardia, and others), or other drugs in this class, was recently...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Bepridil for Angina Pectoris
Article code: 845c
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.